Investigation of the effects of altered receptor binding activity on the clearance of erythropoiesis-stimulating proteins: Nonerythropoietin receptor-mediated pathways may play a major role-Reference-Cited by-同舟云学术

Investigation of the effects of altered receptor binding activity on the clearance of erythropoiesis-stimulating proteins: Nonerythropoietin receptor-mediated pathways may play a major role

Published:2009-06 Issue:6 Volume:98 Page:2198-2211
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Agoram Balaji,Aoki Ken,Doshi Sameer,Gegg Colin,Jang Graham,Molineux Graham,Narhi Linda,Elliott Steve

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference47 articles.

1. Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients;Nissenson;Am J Kidney Dis,2002

2. Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy;Vansteenkiste;J Natl Cancer Inst,2002

3. Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta;Halstenson;Clin Pharmacol Ther,1991

4. Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin;Egrie;Exp Hematol,2003

5. Control of rHuEPO biological activity: the role of carbohydrate;Elliott;Exp Hematol,2004

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Influence of Precursor Depletion and dose Regimens on Resistance to Erythropoiesis-Stimulating Agents: Insights from Simulations with Instantaneous Dose-Adaptation Algorithm;Journal of Pharmaceutical Sciences;2024-01

2. Hematopoietic Growth Factors;Pharmaceutical Biotechnology;2024

3. Sialic Acids Content Analysis of the Innovator and Biosimilar Darbepoetin Alfa by Fluorometric HPLC Assay;Current Pharmaceutical Analysis;2019-03-19

4. Hematopoietic Growth Factors;Pharmaceutical Biotechnology;2019

5. Epoetin beta pegol, but not recombinant erythropoietin, retains its hematopoietic effect in vivo in the presence of the sialic acid-metabolizing enzyme sialidase;International Journal of Hematology;2016-04-15